At Rev.1 Engineering, we turn our client’s concepts into market-ready medical devices through expert engineering, design, and rigorous quality standards. With a focus on safety, efficacy, and manufacturability, we collaborate closely with healthcare innovators throughout the product development lifecycle to bring their ideas to life. Our comprehensive suite of services encompasses: - Program Management - Concept and Feasibility - Ideation / Concept Generation - Device Design - Rapid Prototyping - Design and Development - Risk Management - Design For Manufacturing - V&V Builds - Strategic Manufacturing - Production Planning - Clinical and Commercial Launch Support - Quality Support Our expertise extends to various clinical fields and device experience, including: Clinical Fields: - Structural Heart - Cardiovascular - Gastroenterology - Electrophysiology - Oncology - First-of-Kind Devices Device Experience: - Catheters - Guidewires - Capital Equipment - Smart devices - Wearables
Looking for a particular REV.1 Engineering® - A subsidiary of ASAHI Filmecc. employee's phone or email?
The REV.1 Engineering® - A subsidiary of ASAHI Filmecc. annual revenue was $80.8 million in 2026.
Scott Huter is the CEO of REV.1 Engineering® - A subsidiary of ASAHI Filmecc..
23 people are employed at REV.1 Engineering® - A subsidiary of ASAHI Filmecc..
REV.1 Engineering® - A subsidiary of ASAHI Filmecc. is based in Temecula, California.
The NAICS codes for REV.1 Engineering® - A subsidiary of ASAHI Filmecc. are [339, 33].
The SIC codes for REV.1 Engineering® - A subsidiary of ASAHI Filmecc. are [384, 38].